NUVB logo

Nuvation Bio (NUVB) EBITDA

Annual EBITDA

-$566.91 M
-$491.33 M-650.09%

December 31, 2024


Summary


Performance

NUVB EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNUVBprofitabilitymetrics:

Quarterly EBITDA

-$49.14 M
-$8.21 M-20.06%

December 31, 2024


Summary


Performance

NUVB Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNUVBprofitabilitymetrics:

TTM EBITDA

-$572.32 M
-$35.41 M-6.59%

December 31, 2024


Summary


Performance

NUVB TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNUVBprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

NUVB EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-650.1%-20.1%-6.6%
3 y3 years-508.7%-20.1%-6.6%
5 y5 years-1204.8%-20.1%-6.6%

NUVB EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-650.1%at low-257.8%+89.4%-672.9%at low
5 y5-year-1204.8%at low-446.5%+89.4%-6123.6%at low
alltimeall time-1204.8%at low-446.5%+89.4%-6123.6%at low

Nuvation Bio EBITDA History

DateAnnualQuarterlyTTM
Dec 2024
-$566.91 M(+650.1%)
-$49.14 M(+20.1%)
-$572.32 M(+6.6%)
Sep 2024
-
-$40.93 M(-91.1%)
-$536.92 M(+4.1%)
Jun 2024
-
-$462.12 M(+2194.4%)
-$515.58 M(+596.3%)
Mar 2024
-
-$20.14 M(+46.7%)
-$74.05 M(-7.9%)
Dec 2023
-$75.58 M(-36.8%)
-$13.73 M(-29.9%)
-$80.38 M(-11.6%)
Sep 2023
-
-$19.59 M(-4.8%)
-$90.93 M(-9.6%)
Jun 2023
-
-$20.58 M(-22.2%)
-$100.62 M(-14.6%)
Mar 2023
-
-$26.46 M(+9.0%)
-$117.86 M(-1.4%)
Dec 2022
-$119.53 M
-$24.29 M(-17.1%)
-$119.54 M(-4.2%)
Sep 2022
-
-$29.28 M(-22.6%)
-$124.82 M(+5.5%)
DateAnnualQuarterlyTTM
Jun 2022
-
-$37.82 M(+34.4%)
-$118.25 M(+17.3%)
Mar 2022
-
-$28.15 M(-4.8%)
-$100.83 M(+8.3%)
Dec 2021
-$93.13 M(+114.4%)
-$29.57 M(+30.1%)
-$93.13 M(+20.5%)
Sep 2021
-
-$22.72 M(+11.4%)
-$77.31 M(+16.9%)
Jun 2021
-
-$20.39 M(-0.3%)
-$66.11 M(+20.8%)
Mar 2021
-
-$20.45 M(+48.9%)
-$54.71 M(+25.9%)
Dec 2020
-$43.45 M
-$13.74 M(+19.3%)
-$43.45 M(+46.3%)
Sep 2020
-
-$11.52 M(+28.1%)
-$29.71 M(+63.3%)
Jun 2020
-
-$8.99 M(-2.2%)
-$18.19 M(+97.8%)
Mar 2020
-
-$9.20 M
-$9.20 M

FAQ

  • What is Nuvation Bio annual EBITDA?
  • What is the all time high annual EBITDA for Nuvation Bio?
  • What is Nuvation Bio annual EBITDA year-on-year change?
  • What is Nuvation Bio quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Nuvation Bio?
  • What is Nuvation Bio quarterly EBITDA year-on-year change?
  • What is Nuvation Bio TTM EBITDA?
  • What is the all time high TTM EBITDA for Nuvation Bio?
  • What is Nuvation Bio TTM EBITDA year-on-year change?

What is Nuvation Bio annual EBITDA?

The current annual EBITDA of NUVB is -$566.91 M

What is the all time high annual EBITDA for Nuvation Bio?

Nuvation Bio all-time high annual EBITDA is -$43.45 M

What is Nuvation Bio annual EBITDA year-on-year change?

Over the past year, NUVB annual EBITDA has changed by -$491.33 M (-650.09%)

What is Nuvation Bio quarterly EBITDA?

The current quarterly EBITDA of NUVB is -$49.14 M

What is the all time high quarterly EBITDA for Nuvation Bio?

Nuvation Bio all-time high quarterly EBITDA is -$8.99 M

What is Nuvation Bio quarterly EBITDA year-on-year change?

Over the past year, NUVB quarterly EBITDA has changed by -$8.21 M (-20.06%)

What is Nuvation Bio TTM EBITDA?

The current TTM EBITDA of NUVB is -$572.32 M

What is the all time high TTM EBITDA for Nuvation Bio?

Nuvation Bio all-time high TTM EBITDA is -$9.20 M

What is Nuvation Bio TTM EBITDA year-on-year change?

Over the past year, NUVB TTM EBITDA has changed by -$35.41 M (-6.59%)